Rohto Pharmaceutical Co.,Ltd.
Rohto Pharmaceutical Co.,Ltd. scores highest on Torque (64) and lowest on Price (29). Its PosiPenta is 48.55 out of 100, around the middle of similar companies.
On the Penta Grid this week, Rohto Pharmaceutical Co.,Ltd. is Grid #28 of 42 in the Consumer Defensive sector in Japan, and Grid #274 of 473 in Japan.
Compared with similar companies in the Consumer Defensive sector in Japan.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Rohto Pharmaceutical Co.,Ltd. | 48.55 | 29 | 60 | 56 | 64 | 34 |
| Kewpie Corporation | 53.78 | 25 | 55 | 65 | 67 | 57 |
| Coca-Cola Bottlers Japan Holdings Inc. | 33.09 | 22 | 30 | 42 | 26 | 46 |
| Nisshin Seifun Group Inc. | 51.55 | 53 | 49 | 65 | 48 | 43 |
| NH Foods Ltd. | 51.55 | 62 | 69 | 29 | 33 | 64 |
| Nichirei Corporation | 48.66 | 37 | 65 | 57 | 45 | 39 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 19.65 |
| P/B ratio | 1.98 |
EEarnings
| Trailing EPS | ₹84.02 |
| Forward EPS | ₹101.16 |
NNitro
| Price | 1651.13 |
| 52-week high | 1889.95 |
| 52-week low | 1343.00 |
| Fall from 52-week high | 12.6% |
TTorque
| Return on equity (ROE) | 10.91% |
| Debt-to-equity | 0.18 |
AAnchor
| Beta (price swings) | -0.41 |
| Market cap | ₹37,138 Cr |
| Insider holding | 10.97% |
| Dividend yield | 1.80% |
Figures as used for the week of 24 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Rohto Pharmaceutical Co.,Ltd.'s PosiPenta score?
Rohto Pharmaceutical Co.,Ltd.'s PosiPenta is 48.55 out of 100 for the week of 24 Oct 2026, based on 5 of 5 pillars.
Where does Rohto Pharmaceutical Co.,Ltd. stand on the Penta Grid?
On the Penta Grid this week, Rohto Pharmaceutical Co.,Ltd. is Grid #28 of 42 in the Consumer Defensive sector in Japan, and Grid #274 of 473 in Japan.
Which PosiPenta pillar is strongest for Rohto Pharmaceutical Co.,Ltd.?
Torque (durability), with a score of 64 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Rohto Pharmaceutical Co.,Ltd.?
Price (valuation), with a score of 29 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.